Gilead Sciences To Rally Around 11%? Here Are 10 Top Analyst Forecasts For Tuesday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

Citigroup cut AvePoint, Inc. AVPT price target from $18 to $16. Citigroup analyst Fatima Boolani maintained a Neutral rating. AvePoint shares closed at $13.50 on Monday. See how other analysts view this stock.
BMO Capital boosted the price target for Protagonist Therapeutics, Inc. PTGX from $62 to $72. BMO Capital analyst Etzer Darout maintained an Outperform rating. Protagonist Therapeutics shares closed at $55.95 on Monday. See how other analysts view this stock.
Stifel cut DarioHealth Corp. DRIO price target from $3.5 to $2. Stifel analyst David Grossman maintained a Buy rating. DarioHealth shares closed at $0.6710 on Monday. See how other analysts view this stock.
Oppenheimer slashed the price target for OnKure Therapeutics, Inc. OKUR from $35 to $30. Oppenheimer analyst Matt Biegler maintained an Outperform rating. OnKure Therapeutics shares closed at $4.96 on Monday. See how other analysts view this stock.
Mizuho cut the price target for Venture Global, Inc. VG from $25 to $18. Mizuho analyst Robert Mosca maintained an Outperform rating. Venture Global shares closed at $8.95 on Monday. See how other analysts view this stock.
HC Wainwright & Co. increased Oracle Corporation ORCL price target from $212 to $202. Barclays analyst Raimo Lenschow maintained an Overweight rating. Oracle shares settled at $148.79 on Monday. See how other analysts view this stock.
WestPark Capital slashed SentinelOne, Inc. S price target from $34 to $31. WestPark Capital analyst Casey Ryan maintained a Buy rating. SentinelOne shares closed at $18.17 on Monday. See how other analysts view this stock.
B of A Securities cut Asana, Inc. ASAN price target from $30 to $25. B of A Securities analyst Michael Funk maintained a Buy rating. Asana shares closed at $16.68 on Monday. See how other analysts view this stock.
Canaccord Genuity raised the price target for BlackBerry Limited BB from $3 to $4.75. Canaccord Genuity analyst Kingsley Crane maintained a Hold rating. BlackBerry shares settled at $4.19 on Monday. See how other analysts view this stock.
Morgan Stanley raised Gilead Sciences, Inc. GILD price target from $123 to $130. Morgan Stanley analyst Matthew Harrison maintained an Overweight rating. Gilead Sciences shares closed at $117.21 on Monday. See how other analysts view this stock.